PTCT
PTC Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$64.49
+1.13 ▲ +1.78%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$64.49
+0.00 +0.00%
| Index | RUT | P/E | 8.34 | EPS (ttm) | 7.74 | Insider Own | 9.01% | Shs Outstand | 0.08B | Perf Week | 2.66% |
| Market Cap | 5.34B | Forward P/E | 48.56 | EPS next Y | 292.65% | Insider Trans | -6.97% | Shs Float | 0.08B | Perf Month | -9.07% |
| Enterprise Value | 3.79B | PEG | - | EPS next Q | -0.44 | Inst Own | 112.24% | Short Float | 12.77% | Perf Quarter | -12.97% |
| Income | 0.68B | P/S | 3.08 | EPS this Y | -108.86% | Inst Trans | 18.73% | Short Ratio | 7.62 | Perf Half Y | 5.79% |
| Sales | 1.73B | P/B | - | EPS next 5Y | - | ROA | 29.5% | Short Interest | 9.62M | Perf YTD | -15.1% |
| Book/sh | -2.52 | P/C | 2.74 | EPS past 3/5Y | - | ROE | - | 52W High | -26.3% ($87.50) | Perf Year | 22.23% |
| Cash/sh | 23.5 | P/FCF | 7.6 | Sales past 3/5Y | 35.3% 35.37% | ROIC | - | 52W Low | 79.39% ($35.95) | Perf 3Y | 39.95% |
| Dividend Est. | - | EV/EBITDA | 4.23 | EPS Y/Y TTM | 285.92% | Gross Margin | 95.85% | Volatility(W/M) | 5.26% 4.54% | Perf 5Y | 10.33% |
| Dividend TTM | - | EV/Sales | 2.19 | Sales Y/Y TTM | 114.51% | Oper. Margin | 49.49% | ATR (14) | 3.11 | Perf 10Y | 948.62% |
| Dividend Ex-Date | - | Quick Ratio | 2.27 | EPS Q/Q | -95.99% | Profit Margin | 39.44% | RSI (14) | 39.2 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.35 | Sales Q/Q | -22.75% | SMA20 | -3.98% ($67.16) | Beta | 0.59 | Target Price | $87.57 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -10.37% ($71.95) | Rel Volume | 0.48 | Prev Close | $63.36 |
| Employees | 991 | LT Debt/Eq | - | EPS/Sales Surpr. | -1718.22% -41.08% | SMA200 | 1.87% ($63.31) | Avg Volume(3M) | 1.26M | Price | $64.49 |
| IPO | 2013/6/20 | Option/Short | Yes/Yes | Trades | 10528 | Volume | 605,687 | Change | 1.78% |
뉴스 로딩 중...